C. Mangioni

2.9k total citations
52 papers, 1.6k citations indexed

About

C. Mangioni is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, C. Mangioni has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 13 papers in Oncology and 13 papers in Obstetrics and Gynecology. Recurrent topics in C. Mangioni's work include Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Cervical Cancer and HPV Research (6 papers). C. Mangioni is often cited by papers focused on Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Cervical Cancer and HPV Research (6 papers). C. Mangioni collaborates with scholars based in Italy, Belgium and Netherlands. C. Mangioni's co-authors include Gerardo Zanetta, S. Pecorelli, Giorgio Bolis, Fabio Landoni, Ignace Vergote, C. Madroñal, Saverio Tateo, P.J. Timmers, C. Coens and Massimo Piergiuseppe Franchi and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

C. Mangioni

52 papers receiving 1.5k citations

Peers

C. Mangioni
Soon‐Beom Kang South Korea
M. Piccart Belgium
A.G.J. van der Zee Netherlands
P. Y. Liu United States
Chad M. Michener United States
C. Mangioni
Citations per year, relative to C. Mangioni C. Mangioni (= 1×) peers M Yakushiji

Countries citing papers authored by C. Mangioni

Since Specialization
Citations

This map shows the geographic impact of C. Mangioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mangioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mangioni more than expected).

Fields of papers citing papers by C. Mangioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Mangioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mangioni. The network helps show where C. Mangioni may publish in the future.

Co-authorship network of co-authors of C. Mangioni

This figure shows the co-authorship network connecting the top 25 collaborators of C. Mangioni. A scholar is included among the top collaborators of C. Mangioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Mangioni. C. Mangioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fruscio, Robert, Annalisa Garbi, Gabriella Parma, et al.. (2011). Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer. JNCI Journal of the National Cancer Institute. 103(4). 347–351. 22 indexed citations
2.
Signorelli, Mauro, Alessandra Lissoni, Annalisa Garbi, Patrizia Perego, & C. Mangioni. (2005). Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: A case report and literature review. Gynecologic Oncology. 97(2). 700–703. 11 indexed citations
3.
Vermorken, Jan B., C. Mangioni, S. Pecorelli, et al.. (2000). Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix. International Journal of Gynecological Cancer. 10(5). 358–365. 6 indexed citations
4.
Cicco, Concetta De, Mario Sideri, Mirco Bartolomei, et al.. (2000). Sentinel node biopsy in early vulvar cancer. British Journal of Cancer. 82(2). 295–299. 126 indexed citations
5.
Zanetta, Gerardo, S Rota, Andrea Alberto Lissoni, G Bratina, & C. Mangioni. (1999). Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females. British Journal of Cancer. 80(3-4). 403–406. 19 indexed citations
6.
Lissoni, Andrea Alberto, Antonio Gabriele, Salvatore Tumolo, et al.. (1997). Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma. Annals of Oncology. 8(10). 969–972. 62 indexed citations
7.
Landoni, Fabio, Andrea Maneo, Gennaro Cormio, et al.. (1997). Concurrent carboplatin/5-FU and radiotherapy for locally advanced cervical carcinoma. International Journal of Gynecological Cancer. 7(6). 471–476. 2 indexed citations
8.
Zanetta, Gerardo, Andrea Alberto Lissoni, Valter Torri, et al.. (1996). Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study. BMJ. 313(7065). 1110–1113. 52 indexed citations
9.
10.
Colombo, N., Simone Bini, Dario Di Miceli, et al.. (1995). Weekly cisplatin ± glutathione in relapsed ovarian carcinoma. International Journal of Gynecological Cancer. 5(2). 81–86. 40 indexed citations
11.
Colombo, Nicoletta, Fedro A. Peccatori, C Paganin, et al.. (1992). Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy. International Journal of Cancer. 51(1). 42–46. 61 indexed citations
12.
Durrant, K.R., C. Mangioni, A.J. Lacave, et al.. (1990). Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: A phase II study of the EORTC gynaecological cancer cooperative group (GCCG). Gynecologic Oncology. 37(3). 359–362. 37 indexed citations
13.
Mangioni, C., Giorgio Bolis, S. Pecorelli, et al.. (1989). Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin. JNCI Journal of the National Cancer Institute. 81(19). 1464–1471. 110 indexed citations
14.
Colnaghi, Maria I., G.L. Buraggi, Silvana Canevari, et al.. (1989). Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approaches. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(6). 633–636. 7 indexed citations
15.
Colombo, N., C. Sessa, Fabio Landoni, et al.. (1986). Cisplatin, Vinblastine, and Bleomycin Combination Chemotherapy in Metastatic Granulosa Cell Tumor of the Ovary. Obstetrics and Gynecology. 67(2). 265–268. 82 indexed citations
16.
Colombo, Nicoletta, Enrico Sartori, Fabio Landoni, et al.. (1986). Phase II study of the platinum analog TNO-6 in patients with advanced ovarian cancer.. PubMed. 70(6). 793–4. 3 indexed citations
17.
Mangioni, C., et al.. (1985). Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervix.. PubMed. 201. 225–37. 5 indexed citations
18.
Morasca, L., Eugenio Erba, Massimo Vaghi, et al.. (1984). In vitro cytotoxicity of VP-16213 on human ovarian cancer.. Journal of Experimental & Clinical Cancer Research. 3(3). 305–311. 1 indexed citations
19.
Privitera, Gaetano Pierpaolo, S. Scalambrino, G Ortisi, et al.. (1983). Clinical evaluation of piperacillin in the treatment of severe infections in obstetrics and gynecology. Current Therapeutic Research. 33(6). 881–886. 1 indexed citations
20.
D’Incalci, Maurizio, Giorgio Bolis, C. Mangioni, L. Morasca, & Silvio Garattini. (1978). Variable oral absorption of hexamethylmelamine in man.. PubMed. 62(12). 2117–9. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026